Although CEA, CA19-9 and CA72-4 have been used in cancer diagnosis and prognosis for many years, researchers realize the limited sensitivity and try to find some more sensitive targets, including molecular biomarker, antigenic marker and combined muti-biomarkers [22-26]. Here, CEACAM5 is linked to cancer.